Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1. Liu L, Ruiz J, O'Neill SS, Grant SC, Petty WJ, Yang M, Chen K, Topaloglu U, Pasche B, Zhang W. Mol. Cancer. 2018 04; 17(1):81.
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers. Berger AC, Korkut A, Kanchi RS, Hegde AM, Lenoir W, Liu W, Liu Y, Fan H, Shen H, Ravikumar V, Rao A, Schultz A, Li X, Sumazin P, Williams C, Mestdagh P, Gunaratne PH, Yau C, Bowlby R, Robertson AG, Tiezzi DG, Wang C, Cherniack AD, Godwin AK, Kuderer NM, Rader JS, Zuna RE, Sood AK, Lazar AJ, Ojesina AI, Adebamowo C, Adebamowo SN, Baggerly KA, Chen TW, Chiu HS, Lefever S, Liu L, MacKenzie K, Orsulic S, Roszik J, Shelley CS, Song Q, Vellano CP, Wentzensen N, , Weinstein JN, Mills GB, Levine DA, Akbani R. Cancer Cell. 2018 04; 33(4):690-705.e9.
Annotating function to differentially expressed LincRNAs in myelodysplastic syndrome using a network-based method. Liu K, Beck D, Thoms JAI, Liu L, Zhao W, Pimanda JE, Zhou X. Bioinformatics. 2017 Sep; 33(17):2622-2630.
Mutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center. Kytola V, Topaloglu U, Miller LD, Bitting RL, Goodman MM, D Agostino RB, Desnoyers RJ, Albright C, Yacoub G, Qasem SA, DeYoung B, Thorsson V, Shmulevich I, Yang M, Shcherban A, Pagni M, Liu L, Nykter M, Chen K, Hawkins GA, Grant SC, Petty WJ, Alistar AT, Levine EA, Staren ED, Langefeld CD, Miller V, Singal G, Petro RM, Robinson M, Blackstock W, Powell BL, Wagner LI, Foley KL, Abraham E, Pasche B, Zhang W. Theranostics. 2017; 7(11):2914-2923.
RPI-Bind: a structure-based method for accurate identification of RNA-protein binding sites. Luo J, Liu L, Venkateswaran S, Song Q, Zhou X. Sci Rep. 2017 04; 7(1):614.
